PRESS RELEASE / 2020-03-06
For almost two decades, PCG Solutions has been developing Viedoc™, a market-leading eClinical solution for pharmaceutical companies and organizations conducting clinical trials. Viedoc is applicable across all market segments and used for clinical trials worldwide, meeting all regulatory standards, including ICH GCP, 21 CFR part 11, HIPAA.
PCG Solutions has long been synonymous with its product, which is why the name change to Viedoc Technologies is a natural step to further strengthen the brand around the world.
"This is the beginning of a new chapter. We have an exciting future ahead, continuing our rapid growth trajectory, and the name change reflects our commitment to keep Viedoc at the forefront of eClinical technology," says Mats Klaar CEO.
Continuing the work for a healthier world, Viedoc Technologies remains committed to providing the same degree of excellence to our clients.
For more information, contact:
Mats Klaar, CEO Viedoc Technologies AB, +46 708 244 370,
About Viedoc Technologies
Viedoc Technologies, the developer of the SaaS platform Viedoc™ founded 2003, is headquartered in Uppsala, Sweden, with offices in the U.S., Japan, and China. Viedoc™ is a comprehensive cloud-based platform built to improve the efficiency of data collection in clinical trials. Over 2 000 studies, across all therapeutic areas and clinical phases and in more than 70 countries, have used Viedoc. Created by industry professionals with decades of experience, Viedoc blends innovation with design to simplify the users’ workday. Viedoc Technologies’ mission is to be at the forefront of eClinical innovation by developing new, smarter ways to help clients succeed with their trials.
"Data capturing has been made easy because of viedoc, it is incredibly robust and easy to navigate"